Georgetown University Office of Technology Commercialization

03/28/2019

New I2I (Invention to Innovation) seminar at Georgetown University! Save the date for 4/17 on "PATENTS: FROM INVENTION TO COMMERCIALIZATION IN THE BIOMEDICAL SPACE" presented by Dr. Ling Zhong, Ph.D. and Mr. James M. Gould.
Details here:

The Office of Technology Commercialization Presents Invention 2 Innovation (I2I) PATENTS: FROM INVENTION TO COMMERCIALIZATION IN THE BIOMEDICAL SPACE Wed., April 17, 2019 12:00 pm - 1:30 pm Building D, Warwick Evans Conference Room (New Location) Presented By Dr. Ling Zhong, Ph.D., Shareholder Mr. J...

03/27/2019

We are very excited for Georgetown Lombardi Comprehensive Cancer Center Director Dr. Weiner to receive the 2019 AACR Distinguished Public Service Award in recognition of his extraordinary career in the field of cancer immunology and immunotherapy and for his contribution and proactivity in establishing the AACR Cancer Immunology Task Force and AACR Cancer Immunology Working Group. Georgetown University

01/25/2018

Dr. Jeffrey Toretsky, a pediatric oncologist and researcher at Georgetown Lombardi Comprehensive Cancer Center, will be inducted as a National Academy of Inventors (NAI) Fellow this coming spring.

01/25/2018

Our next I2I is on Mon, Feb. 5th! Come hear a startup story!

The Office of Technology Commercialization Presents Invention 2 Innovation (I2I) Adventures in Entrepreneurship: The Case of Embody Monday, Feb. 5, 2018 12:00 pm - 1:30 pm Leavey Program Room Featuring Jeff Conroy CEO Embody Jeff Conroy has over 25 years of life science experience as an entrepreneur...

10/13/2017

We're excited for the next I2I with StartupHoyas' John Jabara!

The Office of Technology Commercialization Presents Invention 2 Innovation (I2I) Introducing: "Lean Startup" Friday, Oct. 27, 2017 12:00 pm - 1:30 pm Murray Room 5th Floor, Lauinger Library Presented by John Jabara Entrepreneur-in-Residence McDonough School of Business Georgetown UniversityStartupHo...

05/21/2017

Georgetown University today announces it has exclusively licensed worldwide intellectual property (IP) rights to develop and commercialize uses of tyrosine kinase (TK) inhibitors for the treatment of neurodegenerative diseases to Axovant Sciences GmbH.

05/17/2017

Our Spring 2017 newsletter is live! https://goo.gl/i5CwXv

While summer beckons us to vacations and adventures, it is also a time of celebration of accomplishments. OTC offers congratulations to all of Georgetown University’s students who graduate this week (including our own, Jeff Genota, who received his MPS in Technology Management from Georgetown Univer...

02/23/2017

Chemistry professor Toshiko Ichiye is researching on a molecular level how much pressure is necessary to destroy dangerous microbes (such as E. coli bacteria shown here) and how to make sure the microorganisms aren't able to revive themselves.

https://www.georgetown.edu/news/toshiko-ichiye-microbes-NIH-grant

Using a recently received $1.4 million NIH grant, Georgetown chemistry professor Toshiko Ichiye is conducting research that could contribute to the fight against foodborne illness.

02/23/2017

“We found that at this teachable moment — a time when smokers are thinking about their health and may be ready to make a change — offering help makes a difference, and may help save lives,” says the study’s lead researcher, Kathryn L. Taylor, PhD, a behavioral scientist and a professor of oncology at Georgetown Lombardi Comprehensive Cancer Center.

https://gumc.georgetown.edu/news/smoking-cessation-counseling-successful-when-paired-with-lung-cancer-screening

In the first successful randomized trial of its kind, Georgetown Lombardi Comprehensive Cancer Center researchers have provided preliminary evidence that telephone-based smoking cessation counseling given to smokers shortly after undergoing lung cancer screening can be effective at helping people st...

02/02/2017

We're looking forward to honoring Georgetown's inventors next Monday at the event. Learn more here https://otc.georgetown.edu/pac

We would like to thank you for your interest in joining us to recognize achievements in innovation and commercialization at Georgetown University at the biennal Patent Awards Ceremony (PAC). This year's theme is

11/16/2016

Our next I2I is Nov. 30th to discover NCI's "NeXT" program. Please join us! https://goo.gl/xQ2ENL

The Office of Technology Commercialization Presents Invention 2 Innovation (I2I) Collaborative Partnerships for Cancer Drug Discovery and Development: NCI's Experimental Therapeutics (NExT) Program Wednesday, November 30, 2016 12:00 pm - 1:30 pm Leavey Program Room #1606 at the Leavey Center (Across...

11/14/2016

Our next I2I and our Holiday Open House/NAI Induction Ceremony are coming soon! Read more on our Events page for details. https://goo.gl/Sn9y9d And mark your calendars!!

Each year the Office of Technology Commercialization hosts events featuring educational and promotional opportunities for the Georgetown University community and the Washington, D.C. area in the field of technology transfer and intellectual property. Please read further for more information about up...